Cargando…
Growth Hormone Secretagogue Receptor 1A Antagonist JMV2959 Effectively Prevents Morphine Memory Reconsolidation and Relapse
Relapse to drug seeking after prolonged abstinence is a major problem in the clinical treatment of drug addiction. The use of pharmacological interventions to disrupt established drug reward memories is a promising strategy for the treatment of drug addiction. A growth hormone secretagogue receptor...
Autores principales: | Zhao, Jing, Du, Xinyu, Chen, Mingzhu, Zhu, Shimin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666548/ https://www.ncbi.nlm.nih.gov/pubmed/34912212 http://dx.doi.org/10.3389/fphar.2021.718615 |
Ejemplares similares
-
Blockade of growth hormone secretagogue receptor 1A signaling by JMV 2959 attenuates the NMDAR antagonist, phencyclidine-induced impairments in prepulse inhibition
por: Engel, Jörgen A., et al.
Publicado: (2015) -
Ghrelin receptor antagonist JMV2959 blunts cocaine and oxycodone drug-seeking, but not self-administration, in male rats
por: Merritt, Christina R., et al.
Publicado: (2023) -
Growth hormone secretagogues hexarelin and JMV2894 protect skeletal muscle from mitochondrial damages in a rat model of cisplatin-induced cachexia
por: Sirago, Giuseppe, et al.
Publicado: (2017) -
Postretrieval Microinjection of Baclofen Into the Agranular Insular Cortex Inhibits Morphine-Induced CPP by Disrupting Reconsolidation
por: Sun, Kuisheng, et al.
Publicado: (2020) -
LEAP2 Impairs the Capability of the Growth Hormone Secretagogue Receptor to Regulate the Dopamine 2 Receptor Signaling
por: Mustafá, Emilio R., et al.
Publicado: (2021)